Regulations.gov document
Drugs for Human Use; Drug Efficacy Study Implementation; Potassium Aminobenzoate Oral…
Notice · FDA-1977-N-0015 · posted Mar 9, 2022
Key facts
| Document ID | FDA-1977-N-0015-0012 |
|---|---|
| Title | Drugs for Human Use; Drug Efficacy Study Implementation; Potassium Aminobenzoate Oral Preparations; Withdrawal of Hearing Request; Withdrawal of New Drug Application; Final Resolution of Drug Efficacy Study Implementation |
| Document type | Notice |
| Subtype | Withdrawal |
| Agency | FDA |
| Docket | FDA-1977-N-0015 |
| Posted | Mar 9, 2022 |
| Federal Register citation | 87 FR 13294 |
| FR document number | 2022-04971 |
| Comment period opens | Mar 9, 2022 |
| Effective date | Mar 9, 2022 |
At a glance
- 1–9 Pages
- None Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: